Titles
- Application of human factors engineering principles for combination products: questions and answers : guidance for industry and FDA staff1
- Are older workers good for business?1
- Assessing the credibility of computational modeling and simulation in medical device submissions: guidance for industry and Food and Drug Administration staff1
- Becoming less usual: understanding the decline in the number of people with a usual source of care1
- Behavioral health diagnoses and treatment services for children and youth involved with the child welfare system1
- Benefit-risk assessment for new drug and biological products: guidance for industry1
- Breakthrough Devices Program: guidance for industry and Food and Drug Administration staff1
- Building a safe workplace and community1
- Building equitable artificial intelligence in health care: addressing current challenges and exploring future opportunities1
- Building on CalAIM’s housing supports: strengthening Medi-Cal for people experiencing homelessness1
- Building the evidence base for advancing vaccine equity: findings from the P4VE Promising Practices Project1
- Business of healthcare1
- CARES Act: experts identified safeguards to help selected HHS agencies protect against potential political interference : report to congressional requesters1
- CBO’s analysis of the long-term budgetary outlook: presentation at the University of Michigan’s 71st Annual Economic Outlook Conference1
- CBO’s role and most recent long-term budget projections: presentation at a meeting of the National Conference of State Legislatures' budget working group1
- CDC found ways to use data to understand and address COVID-19 health disparities, despite challenges with existing data1
- CDC has improved the nursing home reporting process for COVID-19 Data in NHSN, but challenges remain1
- CDC provided oversight and assistance: however, ELC recipients still faced challenges in implementing COVID-19 screening testing programs1
- CDC’S Vaccines for Children program recipients did not conduct site visits at some providers as required1
- CDC’s internal control weaknesses led to its initial COVID-19 test kit failure, but CDC ultimately created a working test kit1